However, the KEGG pathway enrichment analysis of the DEGs in the Ang II-treated group and the control group revealed diabetic cardiomyopathy, pathways of neurodegeneration, multiple diseases, cardiac muscle contraction, and the ribosome. This evidence concerns the gene AGT and diabetic cardiomyopathy.